90 related articles for article (PubMed ID: 10021419)
21. p53 enhances the fidelity of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase.
Bakhanashvili M
Oncogene; 2001 Nov; 20(52):7635-44. PubMed ID: 11753641
[TBL] [Abstract][Full Text] [Related]
22. Reverse transcriptase incorporation of 1,5-anhydrohexitol nucleotides.
Vastmans K; Froeyen M; Kerremans L; Pochet S; Herdewijn P
Nucleic Acids Res; 2001 Aug; 29(15):3154-63. PubMed ID: 11470872
[TBL] [Abstract][Full Text] [Related]
23. Mutational analysis of Phe160 within the "palm" subdomain of human immunodeficiency virus type 1 reverse transcriptase.
Gutiérrez-Rivas M; Ibáñez A; Martínez MA; Domingo E; Menéndez-Arias L
J Mol Biol; 1999 Jul; 290(3):615-25. PubMed ID: 10395818
[TBL] [Abstract][Full Text] [Related]
24. A role for dNTP binding of human immunodeficiency virus type 1 reverse transcriptase in viral mutagenesis.
Weiss KK; Chen R; Skasko M; Reynolds HM; Lee K; Bambara RA; Mansky LM; Kim B
Biochemistry; 2004 Apr; 43(15):4490-500. PubMed ID: 15078095
[TBL] [Abstract][Full Text] [Related]
25. Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase.
Boyer PL; Sarafianos SG; Arnold E; Hughes SH
J Virol; 2001 May; 75(10):4832-42. PubMed ID: 11312355
[TBL] [Abstract][Full Text] [Related]
26. Polycitone A, a novel and potent general inhibitor of retroviral reverse transcriptases and cellular DNA polymerases.
Loya S; Rudi A; Kashman Y; Hizi A
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):85-92. PubMed ID: 10548537
[TBL] [Abstract][Full Text] [Related]
27. Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138.
Pelemans H; Aertsen A; Van Laethem K; Vandamme AM; De Clercq E; Pérez-Pérez MJ; San-Félix A; Velázquez S; Camarasa MJ; Balzarini J
Virology; 2001 Feb; 280(1):97-106. PubMed ID: 11162823
[TBL] [Abstract][Full Text] [Related]
28. Mutational analysis of trp-229 of human immunodeficiency virus type 1 reverse transcriptase (RT) identifies this amino acid residue as a prime target for the rational design of new non-nucleoside RT inhibitors.
Pelemans H; Esnouf R; De Clercq E; Balzarini J
Mol Pharmacol; 2000 May; 57(5):954-60. PubMed ID: 10779379
[TBL] [Abstract][Full Text] [Related]
29. Quantitative analysis of the interactions between HIV-1 integrase and retroviral reverse transcriptases.
Herschhorn A; Oz-Gleenberg I; Hizi A
Biochem J; 2008 May; 412(1):163-70. PubMed ID: 18260826
[TBL] [Abstract][Full Text] [Related]
30. Indolopyridones inhibit human immunodeficiency virus reverse transcriptase with a novel mechanism of action.
Jochmans D; Deval J; Kesteleyn B; Van Marck H; Bettens E; De Baere I; Dehertogh P; Ivens T; Van Ginderen M; Van Schoubroeck B; Ehteshami M; Wigerinck P; Götte M; Hertogs K
J Virol; 2006 Dec; 80(24):12283-92. PubMed ID: 17020946
[TBL] [Abstract][Full Text] [Related]
31. Introduction of the alpha-P-borano-group into deoxynucleoside triphosphates increases their selectivity to HIV-1 reverse transcriptase relative to DNA polymerases.
Dobrikov MI; Grady KM; Shaw BR
Nucleosides Nucleotides Nucleic Acids; 2003 Mar; 22(3):275-82. PubMed ID: 12816386
[TBL] [Abstract][Full Text] [Related]
32. Structural alterations in the DNA ahead of the primer terminus during displacement synthesis by reverse transcriptases.
Winshell J; Champoux JJ
J Mol Biol; 2001 Mar; 306(5):931-43. PubMed ID: 11237609
[TBL] [Abstract][Full Text] [Related]
33. Chimeric thermostable DNA polymerases with reverse transcriptase and attenuated 3'-5' exonuclease activity.
Schönbrunner NJ; Fiss EH; Budker O; Stoffel S; Sigua CL; Gelfand DH; Myers TW
Biochemistry; 2006 Oct; 45(42):12786-95. PubMed ID: 17042497
[TBL] [Abstract][Full Text] [Related]
34. Stepping statistics of single HIV-1 reverse transcriptase molecules during DNA polymerization.
Ortiz TP; Marshall JA; Meyer LA; Davis RW; Macosko JC; Hatch J; Keller DJ; Brozik JA
J Phys Chem B; 2005 Aug; 109(33):16127-31. PubMed ID: 16853049
[TBL] [Abstract][Full Text] [Related]
35. Mechanistic basis of zidovudine hypersusceptibility and lamivudine resistance conferred by the deletion of codon 69 in the HIV-1 reverse transcriptase coding region.
Kisic M; Mendieta J; Puertas MC; Parera M; Martínez MA; Martinez-Picado J; Menéndez-Arias L
J Mol Biol; 2008 Oct; 382(2):327-41. PubMed ID: 18662701
[TBL] [Abstract][Full Text] [Related]
36. Impact of the translocational equilibrium of HIV-1 reverse transcriptase on the efficiency of mismatch extensions and the excision of mispaired nucleotides.
Marchand B; Götte M
Int J Biochem Cell Biol; 2004 Sep; 36(9):1823-35. PubMed ID: 15183347
[TBL] [Abstract][Full Text] [Related]
37. The amino acid Asn136 in HIV-1 reverse transcriptase (RT) maintains efficient association of both RT subunits and enables the rational design of novel RT inhibitors.
Balzarini J; Auwerx J; Rodríguez-Barrios F; Chedad A; Farkas V; Ceccherini-Silberstein F; García-Aparicio C; Velázquez S; De Clercq E; Perno CF; Camarasa MJ; Gago F
Mol Pharmacol; 2005 Jul; 68(1):49-60. PubMed ID: 15833734
[TBL] [Abstract][Full Text] [Related]
38. Influence of the linkage between leaving group and nucleoside on substrate efficiency for incorporation in DNA catalyzed by reverse transcriptase.
Giraut A; Herdewijn P
Chembiochem; 2010 Jul; 11(10):1399-403. PubMed ID: 20533494
[TBL] [Abstract][Full Text] [Related]
39. Polymerase-dependent DNA synthesis from phosphoramidate-activated nucleotides.
Yang S; Herdewijn P
Nucleosides Nucleotides Nucleic Acids; 2011; 30(7-8):597-608. PubMed ID: 21888550
[TBL] [Abstract][Full Text] [Related]
40. Effects of nucleotides and nucleotide analogue inhibitors of HIV-1 reverse transcriptase in a ratchet model of polymerase translocation.
Götte M
Curr Pharm Des; 2006; 12(15):1867-77. PubMed ID: 16724953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
